Skip to main content
Erschienen in: Supportive Care in Cancer 1/2020

29.04.2019 | Original Article

Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors

verfasst von: Gabriela Toledo, Carol Y. Ochoa, Albert J. Farias

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Adjuvant endocrine therapy (AET) significantly reduces recurrence and mortality in women with estrogen receptor-positive breast cancer. Adherence to AET is about 50–60% for 5 years, and while numerous studies have identified barriers to AET adherence, few have identified the role of social support as a facilitator. Therefore, the objective of this study is to explore the role of social support during the ongoing management of AET.

Methods

We conducted semi-structured in-depth interviews with breast cancer survivors (n = 22) who filled a prescription for AET in the previous 12 months. Women were recruited from Los Angeles, California, and Houston, Texas, between 2014 and 2015. Interview questions prompted discussion about AET and how social support affects AET adherence. We analyzed interview transcripts with a grounded theory approach and grouped social support into four categories (emotional, informational, instrumental, and appraisal), then used a thematic content analysis to identify the sources and delivery of support.

Results

Women described that informational support was provided by medical providers who explained the purpose, benefits, and management of AET. Emotional support in the form of reassurance, communication, and empathy was provided by family, survivorship groups, medical providers, and spirituality/religiosity. Women identified several organizations and exercises that provided them with instrumental and appraisal support in the form of physical and emotional benefits, which was also provided by family, friends, and medical providers.

Conclusion

We identified that social support delivered to breast cancer survivors provided women with educational, physical, and emotional benefits that may play an important role in their continuation of AET.
Literatur
1.
Zurück zum Zitat American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Atlanta: American Cancer Society, Inc. 2017. American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Atlanta: American Cancer Society, Inc. 2017.
2.
Zurück zum Zitat NCCN Breast Cancer Clinical Practice Guidelines in Oncology, 2014. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed February 7, 2018. NCCN Breast Cancer Clinical Practice Guidelines in Oncology, 2014. Available at: https://​www.​nccn.​org/​professionals/​physician_​gls/​pdf/​breast.​pdf.​ Accessed February 7, 2018. 
3.
Zurück zum Zitat DeSantis C et al (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62CrossRef DeSantis C et al (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62CrossRef
4.
Zurück zum Zitat Howell A et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365(9453):60–62CrossRef Howell A et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365(9453):60–62CrossRef
5.
Zurück zum Zitat Davies C et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771–784CrossRef Davies C et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771–784CrossRef
6.
Zurück zum Zitat Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26(4):556–562CrossRef Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26(4):556–562CrossRef
7.
Zurück zum Zitat Sedjo RL, Devine S (2011) Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat 125(1):191–200CrossRef Sedjo RL, Devine S (2011) Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat 125(1):191–200CrossRef
8.
Zurück zum Zitat Farias AJ, Ornelas IJ, Hohl SD, Zeliadt SB, Hansen RN, Li CI, Thompson B (2017) Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Support Care Cancer 25(1):75–83CrossRef Farias AJ, Ornelas IJ, Hohl SD, Zeliadt SB, Hansen RN, Li CI, Thompson B (2017) Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Support Care Cancer 25(1):75–83CrossRef
9.
Zurück zum Zitat Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19(2):322–328CrossRef Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19(2):322–328CrossRef
10.
Zurück zum Zitat Strom JL, Egede LE (2012) The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep 12(6):769–781CrossRef Strom JL, Egede LE (2012) The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep 12(6):769–781CrossRef
11.
Zurück zum Zitat House JS (1981) Work stress and social support. Addison-Wesley, Reading House JS (1981) Work stress and social support. Addison-Wesley, Reading
12.
Zurück zum Zitat van Dam HA et al (2005) Social support in diabetes: a systematic review of controlled intervention studies. Patient Educ Couns 59(1):1–12CrossRef van Dam HA et al (2005) Social support in diabetes: a systematic review of controlled intervention studies. Patient Educ Couns 59(1):1–12CrossRef
13.
Zurück zum Zitat van Londen GJ, Donovan HS, Beckjord EB, Cardy AL, Bovbjerg DH, Davidson NE, Morse JQ, Switzer GE, Verdonck-de Leeuw IM, Dew MA (2014) Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms. Oncol Nurs Forum 41(6):660–668CrossRef van Londen GJ, Donovan HS, Beckjord EB, Cardy AL, Bovbjerg DH, Davidson NE, Morse JQ, Switzer GE, Verdonck-de Leeuw IM, Dew MA (2014) Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms. Oncol Nurs Forum 41(6):660–668CrossRef
14.
Zurück zum Zitat Samuel CA, Turner K, Donovan HAS, Beckjord E, Cardy A, Dew MA, van Londen GJ (2017) Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management. Support Care Cancer 25(12):3723–3731CrossRef Samuel CA, Turner K, Donovan HAS, Beckjord E, Cardy A, Dew MA, van Londen GJ (2017) Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management. Support Care Cancer 25(12):3723–3731CrossRef
15.
Zurück zum Zitat Yamamoto S, Tazumi K, Arao H (2015) Support not corresponding to transition to a new treatment: women’s perceptions of support provided by their male partners during hormonal therapy. Int J Qual Stud Health Well-being 10:29283CrossRef Yamamoto S, Tazumi K, Arao H (2015) Support not corresponding to transition to a new treatment: women’s perceptions of support provided by their male partners during hormonal therapy. Int J Qual Stud Health Well-being 10:29283CrossRef
16.
Zurück zum Zitat Ford ME, Tilley BC, McDonald PE (1998) Social support among African-American adults with diabetes. Part 1: theoretical framework. J Natl Med Assoc 90(6):361–365PubMedPubMedCentral Ford ME, Tilley BC, McDonald PE (1998) Social support among African-American adults with diabetes. Part 1: theoretical framework. J Natl Med Assoc 90(6):361–365PubMedPubMedCentral
17.
Zurück zum Zitat Cohen, S., et al., Social support: theory, research and applications. 1985CrossRef Cohen, S., et al., Social support: theory, research and applications. 1985CrossRef
18.
Zurück zum Zitat Cohen S, Wills TA (1985) Stress, social support, and the buffering hypothesis. Psychol Bull 98(2):310–357CrossRef Cohen S, Wills TA (1985) Stress, social support, and the buffering hypothesis. Psychol Bull 98(2):310–357CrossRef
19.
Zurück zum Zitat Vaux A (1988) Social support: theory, research, and intervention. Social support: theory, research, and intervention. England: Praeger Publishers. xiv, New York, p 346 Vaux A (1988) Social support: theory, research, and intervention. Social support: theory, research, and intervention. England: Praeger Publishers. xiv, New York, p 346
20.
Zurück zum Zitat Thoits, P.A., Social support and psychological well-being: theoretical possibilities. . Social support: theory, research, and application, ed. S.B. Sarason IG. 1985 Thoits, P.A., Social support and psychological well-being: theoretical possibilities. . Social support: theory, research, and application, ed. S.B. Sarason IG. 1985
21.
Zurück zum Zitat Kroenke C et al (2018) Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat 170(3):623–631CrossRef Kroenke C et al (2018) Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat 170(3):623–631CrossRef
22.
Zurück zum Zitat Lambert LK, Balneaves LG, Howard AF, Gotay CC (2018) Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review. Breast Cancer Res Treat 167(3):615–633CrossRef Lambert LK, Balneaves LG, Howard AF, Gotay CC (2018) Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review. Breast Cancer Res Treat 167(3):615–633CrossRef
23.
Zurück zum Zitat Wuensch P, Hahne A, Haidinger R, Meißler K, Tenter B, Stoll C, Senf B, Huebner J (2015) Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor? J Cancer Res Clin Oncol 141(1):55–60CrossRef Wuensch P, Hahne A, Haidinger R, Meißler K, Tenter B, Stoll C, Senf B, Huebner J (2015) Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor? J Cancer Res Clin Oncol 141(1):55–60CrossRef
24.
Zurück zum Zitat Lambert LK, Balneaves LG, Howard AF, Chia SK, Gotay CC (2018) Understanding adjuvant endocrine therapy persistence in breast cancer survivors. BMC Cancer 18(1):732CrossRef Lambert LK, Balneaves LG, Howard AF, Chia SK, Gotay CC (2018) Understanding adjuvant endocrine therapy persistence in breast cancer survivors. BMC Cancer 18(1):732CrossRef
25.
Zurück zum Zitat Lotzke D et al (2016) Iyengar-Yoga compared to exercise as a therapeutic intervention during (neo)adjuvant therapy in women with stage I-III breast cancer: health-related quality of life, mindfulness, spirituality, life satisfaction, and cancer-related fatigue. Evid Based Complement Alternat Med 2016:5931816CrossRef Lotzke D et al (2016) Iyengar-Yoga compared to exercise as a therapeutic intervention during (neo)adjuvant therapy in women with stage I-III breast cancer: health-related quality of life, mindfulness, spirituality, life satisfaction, and cancer-related fatigue. Evid Based Complement Alternat Med 2016:5931816CrossRef
26.
Zurück zum Zitat Ekinci E, Nathoo S, Korattyil T, Vadhariya A, Zaghloul HA, Niravath PA, Abughosh SM, Trivedi MV (2018) Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? J Cancer Surviv 12(3):348–356CrossRef Ekinci E, Nathoo S, Korattyil T, Vadhariya A, Zaghloul HA, Niravath PA, Abughosh SM, Trivedi MV (2018) Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? J Cancer Surviv 12(3):348–356CrossRef
27.
Zurück zum Zitat Murphy C et al (2012) Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 134(2):459–478CrossRef Murphy C et al (2012) Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 134(2):459–478CrossRef
28.
Zurück zum Zitat Cahir C, Guinan E, Dombrowski SU, Sharp L, Bennett K (2015) Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I–III breast cancer: a systematic review and meta-analysis. Patient Educ Couns 98(12):1524–1539CrossRef Cahir C, Guinan E, Dombrowski SU, Sharp L, Bennett K (2015) Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I–III breast cancer: a systematic review and meta-analysis. Patient Educ Couns 98(12):1524–1539CrossRef
Metadaten
Titel
Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors
verfasst von
Gabriela Toledo
Carol Y. Ochoa
Albert J. Farias
Publikationsdatum
29.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04814-0

Weitere Artikel der Ausgabe 1/2020

Supportive Care in Cancer 1/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.